Katherine Matthay, MD
Recall Professor
Pediatrics
School of Medicine

Dr. Katherine Matthay is the chief of Pediatric Hematology-Oncology at UCSF Benioff Children's Hospital and has been focused for more than 20 years on translational research in neuroblastoma, a deadly childhood cancer. At UCSF, she has developed and led multiple trials using a unique targeted radiopharmaceutical, 131I-MIBG for neuroblastoma.

Show full bio (29 words) Hide full bio

Dr. Matthay also leads the UCSF Pediatric Malignancies Program and an NIH funded Phase I New Approaches to Neuroblastoma Therapy consortium (NANT) for treatment of relapsed and resistant neuroblastoma.

Websites

Show all (3) Hide

• Profile at UCSF Cancer Center (cancer.ucsf.edu)
• Clinical Profile at UCSF Benioff Children's Hospital (ucsfbenioffchildrens.org)
• UCSF Children's Cancer Program (kidscancertrials.ucsf.edu)

Grants and Projects

Show all (6) Hide

• Cancer Center Support Grant, NIH, 1999-2023
• Biology and Therapy of High Risk Neuroblastoma, NIH/NCI, 2000-2015
• Pediatric Clinical Research Center, NIH, 1981-2007
• 131 I-MIBG Escalating Dose Rapid Sequence Double Infusi*, NIH, 2003-2006
• Childrens Cancer Group, NIH, 1978-2002
• Treatment of Leukemia by Antibody-directed Liposomes, NIH, 1985-1992

Publications (325)

Top publication keywords:
InfantChild3-IodobenzylguanidineBone Marrow TransplantationChild, PreschoolN-Myc Proto-Oncogene ProteinHematopoietic Stem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsOncogene ProteinsNeuroblastomaAntineoplastic AgentsRadiopharmaceuticalsNeoplasm Recurrence, LocalIsotretinoinIodine Radioisotopes

• Editor's Note: Inhibition of Phosphatidylinositol 3-Kinase Destabilizes Mycn Protein and Blocks Malignant Progression in Neuroblastoma.
  Cancer research 2024 Chesler L, Schlieve C, Goldenberg DD, Kenney A, Kim G, McMillan A, Matthay KK, Rowitch D, Weiss WA
• Aurora Kinase A inhibition enhances DNA damage and tumor cell death with 131I-MIBG therapy in high-risk neuroblastoma.
  EJNMMI research 2024 Kumar P, Koach J, Nekritz E, Mukherjee S, Braun BS, DuBois SG, Nasholm N, Haas-Kogan D, Matthay KK, Weiss WA, Gustafson C, Seo Y
• Long-term follow-up of patients with intermediate-risk neuroblastoma treated with response- and biology-based therapy: A report from the Children's Oncology Group study ANBL0531.
  Pediatric blood & cancer 2024 Barr EK, Naranjo A, Twist CJ, Tenney SC, Schmidt ML, London WB, Gastier-Foster J, Adkins ES, Mattei P, Handler MH, Matthay KK, Park JR, Maris JM, Desai AV, Cohn SL
• Late cognitive and adaptive outcomes of patients with neuroblastoma-associated opsoclonus-myoclonus-ataxia-syndrome: A report from the Children's Oncology Group.
  Pediatric blood & cancer 2024 Kumar P, Willard VW, Embry L, Naranjo A, LaBarre B, Matthay KK, de Alarcon PA
• ALK upregulates POSTN and WNT signaling to drive neuroblastoma.
  Cell reports 2024 Huang M, Fang W, Farrel A, Li L, Chronopoulos A, Nasholm N, Cheng B, Zheng T, Yoda H, Barata MJ, Porras T, Miller ML, Zhen Q, Ghiglieri L, McHenry L, Wang L, Asgharzadeh S, Park J, Gustafson WC, …

Show all (320 more) Hide

• Aurora Kinase A inhibition enhances DNA damage and tumor cell death with 131I-MIBG therapy in high-risk neuroblastoma.
  Research square 2024 Kumar P, Koach J, Nekritz E, Mukherjee S, Braun BS, DuBois SG, Nasholm N, Haas-Kogan D, Matthay KK, Weiss WA, Gustafson C, Seo Y
• Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial.
  British journal of cancer 2024 Hogarty MD, Ziegler DS, Franson A, Chi YY, Tsao-Wei D, Liu K, Vemu R, Gerner EW, Bruckheimer E, Shamirian A, Hasenauer B, Balis FM, Groshen S, Norris MD, Haber M, Park JR, Matthay KK, Marachelian A
• Pediatric neuroblastoma with intraspinal extension: the role of surgical management.
  Journal of neurosurgery. Pediatrics 2023 Chang D, Oh T, Roland JL, Matthay KK, Vo KT, Edwards CS, Sun PP, Auguste KI, Gupta N
• Norepinephrine transporter and vesicular monoamine transporter 2 tumor expression as a predictor of response to 131 I-MIBG in patients with relapsed/refractory neuroblastoma.
  Pediatric blood & cancer 2023 Batra V, Gikandi A, Pawel B, Martinez D, Granger MM, Marachelian A, Park JR, Maris JM, Vo KT, Matthay KK, DuBois SG
• Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastoma.
  Cell reports 2023 Rosenberg MI, Greenstein E, Buchkovich M, Peres A, Santoni-Rugiu E, Yang L, Mikl M, Vaksman Z, Gibbs DL, Reshef D, Salovin A, Irwin MS, Naranjo A, Ulitsky I, de Alarcon PA, Matthay KK, Weigman V, …
• Impact of diagnostic and end-of-induction Curie scores with tandem high-dose chemotherapy and autologous transplants for metastatic high-risk neuroblastoma: A report from the Children's Oncology Group.
  Pediatric blood & cancer 2023 Streby KA, Parisi MT, Shulkin BL, LaBarre B, Bagatell R, Diller L, Grupp SA, Matthay KK, Voss SD, Yu AL, London WB, Park JR, Yanik GA, Naranjo A
• Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results.
  Nature medicine 2023 Goldsmith KC, Park JR, Kayser K, Malvar J, Chi YY, Groshen SG, Villablanca JG, Krytska K, Lai LM, Acharya PT, Goodarzian F, Pawel B, Shimada H, Ghazarian S, States L, Marshall L, Chesler L, Granger M,…
• Modulation of Radiation Biomarkers in a Randomized Phase II Study of 131I-MIBG With or Without Radiation Sensitizers for Relapsed or Refractory Neuroblastoma.
  International journal of radiation oncology, biology, physics 2022 Campbell K, Groshen S, Evans AC, Wilson S, Sebastian A, Loots GG, Marachelian A, Armant M, Pal S, Haas-Kogan DA, Park JR, Granger M, Matthay KK, Coleman MA, DuBois SG
• Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting.
  Cancer 2022 Park JR, Villablanca JG, Hero B, Kushner BH, Wheatley K, Beiske KH, Ladenstein RL, Baruchel S, Macy ME, Moreno L, Seibel NL, Pearson AD, Matthay KK, Valteau-Couanet D
• Outcomes Following GD2-Directed Postconsolidation Therapy for Neuroblastoma After Cessation of Random Assignment on ANBL0032: A Report From the Children's Oncology Group.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022 Desai AV, Gilman AL, Ozkaynak MF, Naranjo A, London WB, Tenney SC, Diccianni M, Hank JA, Parisi MT, Shulkin BL, Smith M, Moscow JA, Shimada H, Matthay KK, Cohn SL, Maris JM, Bagatell R, Sondel PM, …
• Advancing therapy for neuroblastoma.
  Nature reviews. Clinical oncology 2022 Qiu B, Matthay KK
• Pattern and predictors of sites of relapse in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.
  Pediatric blood & cancer 2022 Vo KT, DuBois SG, Neuhaus J, Braunstein SE, Weil BR, Naranjo A, Irtan S, Balaguer J, Matthay KK
• Peripheral Blood Transcript Signatures after Internal 131I-mIBG Therapy in Relapsed and Refractory Neuroblastoma Patients Identifies Early and Late Biomarkers of Internal 131I Exposures.
  Radiation research 2022 Evans AC, Setzkorn T, Edmondson DA, Segelke H, Wilson PF, Matthay KK, Granger MM, Marachelian A, Haas-Kogan DA, DuBois SG, Coleman MA
• Global Neuroblastoma Network: An international multidisciplinary neuroblastoma tumor board for resource-limited countries.
  Pediatric blood & cancer 2022 Matthay KK, Hylton J, Penumarthy N, Khattab M, Soh SY, Nguyen HTK, Alcasabas AP, Fawzy M, Saab R, Khan MS, Ghandour K, Chantada G, Parikh NS, Faulkner L, Lam CG, Howard SC
• Anatomic patterns of relapse and progression following treatment with 131 I-MIBG in relapsed or refractory neuroblastoma.
  Pediatric blood & cancer 2021 Fishel Ben Kenan R, Polishchuk AL, Hawkins RA, Braunstein SE, Matthay KK, DuBois SG, Haas-Kogan DA
• Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2021 DuBois SG, Granger MM, Groshen S, Tsao-Wei D, Ji L, Shamirian A, Czarnecki S, Goodarzian F, Berkovich R, Shimada H, Villablanca JG, Vo KT, Pinto N, Mosse YP, Maris JM, Shusterman S, Cohn SL, Goldsmith…
• A safety and feasibility trial of 131 I-MIBG in newly diagnosed high-risk neuroblastoma: A Children's Oncology Group study.
  Pediatric blood & cancer 2021 Weiss BD, Yanik G, Naranjo A, Zhang FF, Fitzgerald W, Shulkin BL, Parisi MT, Russell H, Grupp S, Pater L, Mattei P, Mosse Y, Lai HA, Jarzembowski JA, Shimada H, Villablanca JG, Giller R, Bagatell R, …
• Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2021 Yu AL, Gilman AL, Ozkaynak MF, Naranjo A, Diccianni MB, Gan J, Hank JA, Batova A, London WB, Tenney SC, Smith M, Shulkin BL, Parisi M, Matthay KK, Cohn SL, Maris JM, Bagatell R, Park JR, Sondel PM
• Association of image-defined risk factors with clinical features, histopathology, and outcomes in neuroblastoma.
  Cancer medicine 2020 Temple WC, Vo KT, Matthay KK, Balliu B, Coleman C, Michlitsch J, Phelps A, Behr S, Zapala MA
• Germline MUTYH Mutation in a Pediatric Cancer Survivor Developing a Secondary Malignancy.
  Journal of pediatric hematology/oncology 2020 Lavergne V, Sabnis A, Tupule A, Davidson PR, Kline C, Matthay K, Nicolaides T, Goldsby R, Braunstein S, Fogh SE, Sneed PK, Menzel P, Nakamura A, DuBois SG, Haas-Kogan DA, Nakamura JL
• 124I-MIBG PET/CT to Monitor Metastatic Disease in Children with Relapsed Neuroblastoma.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2020 Aboian MS, Huang SY, Hernandez-Pampaloni M, Hawkins RA, VanBrocklin HF, Huh Y, Vo KT, Gustafson WC, Matthay KK, Seo Y
• Differences in Genomic Profiles and Outcomes Between Thoracic and Adrenal Neuroblastoma.
  Journal of the National Cancer Institute 2019 Oldridge DA, Truong B, Russ D, DuBois SG, Vaksman Z, Mosse YP, Diskin SJ, Maris JM, Matthay KK
• Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2019 Chévez-Barrios P, Eagle RC, Krailo M, Piao J, Albert DM, Gao Y, Vemuganti G, Ali MJ, Khetan V, Honavar SG, O'Brien J, Leahey AM, Matthay K, Meadows A, Chintagumpala M
• Maintaining Outstanding Outcomes Using Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2019 Twist CJ, Schmidt ML, Naranjo A, London WB, Tenney SC, Marachelian A, Shimada H, Collins MH, Esiashvili N, Adkins ES, Mattei P, Handler M, Katzenstein H, Attiyeh E, Hogarty MD, Gastier-Foster J, …
• Congenital malformation syndromes associated with peripheral neuroblastic tumors: A systematic review.
  Pediatric blood & cancer 2019 Sznewajs A, Pon E, Matthay KK
• Risk Factors for Transplant-Associated Thrombotic Microangiopathy after Autologous Hematopoietic Cell Transplant in High-Risk Neuroblastoma.
  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2019 Tolbert VP, Dvorak CC, Golden C, Vissa M, El-Haj N, Perwad F, Matthay KK, Vo KT
• Comprehensive evaluation of context dependence of the prognostic impact of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.
  Pediatric blood & cancer 2019 Campbell K, Shyr D, Bagatell R, Fischer M, Nakagawara A, Nieto AC, Brodeur GM, Matthay KK, London WB, DuBois SG
• Role of the extent of prophylactic regional lymph node radiotherapy on survival in high-risk neuroblastoma: A report from the COG A3973 study.
  Pediatric blood & cancer 2019 Braunstein SE, London WB, Kreissman SG, Villablanca JG, Davidoff AM, DeSantes K, Castleberry RP, Murray K, Diller L, Matthay K, Cohn SL, Shulkin B, von Allmen D, Parisi MT, Van Ryn C, Park JR, La …
• Technical Note: Simplified and practical pretherapy tumor dosimetry - A feasibility study for 131 I-MIBG therapy of neuroblastoma using 124 I-MIBG PET/CT.
  Medical physics 2019 Seo Y, Huh Y, Huang SY, Hernandez-Pampaloni JM, Hawkins RA, Gustafson WC, Vo KT, Matthay KK
• Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children's Oncology Group Study ANBL0531.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2018 Twist CJ, Naranjo A, Schmidt ML, Tenney SC, Cohn SL, Meany HJ, Mattei P, Adkins ES, Shimada H, London WB, Park JR, Matthay KK, Maris JM
• Interleukin 2 plus anti-GD2 immunotherapy: helpful or harmful?
  The Lancet. Oncology 2018 Matthay KK
• Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2018 DuBois SG, Mosse YP, Fox E, Kudgus RA, Reid JM, McGovern R, Groshen S, Bagatell R, Maris JM, Twist CJ, Goldsmith K, Granger MM, Weiss B, Park JR, Macy ME, Cohn SL, Yanik G, Wagner LM, Hawkins R, …
• Surveillance Screening in Li-Fraumeni Syndrome: Raising Awareness of False Positives.
  Cureus 2018 Kumar P, Gill RM, Phelps A, Tulpule A, Matthay K, Nicolaides T
• Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial.
  Pediatric blood & cancer 2018 Pinto N, DuBois SG, Marachelian A, Diede SJ, Taraseviciute A, Glade Bender JL, Tsao-Wei D, Groshen SG, Reid JM, Haas-Kogan DA, Reynolds CP, Kang MH, Irwin MS, Macy ME, Villablanca JG, Matthay KK, Park…
• Neuroblastoma: clinical and biological approach to risk stratification and treatment.
  Cell and tissue research 2018 Tolbert VP, Matthay KK
• Predictors of response, progression-free survival, and overall survival using NANT Response Criteria (v1.0) in relapsed and refractory high-risk neuroblastoma.
  Pediatric blood & cancer 2018 Villablanca JG, Ji L, Shapira-Lewinson A, Marachelian A, Shimada H, Hawkins RA, Pampaloni M, Lai H, Goodarzian F, Sposto R, Park JR, Matthay KK
• Estimation of intra-arterial chemotherapy distribution to the retina in pediatric retinoblastoma patients using quantitative digital subtraction angiography.
  Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences 2018 Kondapavulur S, Cooke DL, Kao A, Amans MR, Alexander M, Darflinger R, Dowd CF, Higashida RT, Damato B, Halbach VV, Matthay KK, Hetts SW
• Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial.
  The Lancet. Child & adolescent health 2017 de Alarcon PA, Matthay KK, London WB, Naranjo A, Tenney SC, Panzer JA, Hogarty MD, Park JR, Maris JM, Cohn SL
• Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Erbe AK, Wang W, Carmichael L, Kim K, Mendonça EA, Song Y, Hess D, Reville PK, London WB, Naranjo A, Hank JA, Diccianni MB, Reisfeld RA, Gillies SD, Matthay KK, Cohn SL, Hogarty MD, Maris JM, Park JR,…
• Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trials.
  European journal of nuclear medicine and molecular imaging 2017 Ladenstein R, Lambert B, Pötschger U, Castellani MR, Lewington V, Bar-Sever Z, Oudoux A, Sliwinska A, Taborska K, Biassoni L, Yanik GA, Naranjo A, Parisi MT, Shulkin BL, Nadel H, Gelfand MJ, Matthay …
• Validation of Postinduction Curie Scores in High-Risk Neuroblastoma: A Children's Oncology Group and SIOPEN Group Report on SIOPEN/HR-NBL1.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2017 Yanik GA, Parisi MT, Naranjo A, Nadel H, Gelfand MJ, Park JR, Ladenstein RL, Poetschger U, Boubaker A, Valteau-Couanet D, Lambert B, Castellani MR, Bar-Sever Z, Oudoux A, Kaminska A, Kreissman SG, …
• Association of MYCN copy number with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group.
  Cancer 2017 Campbell K, Gastier-Foster JM, Mann M, Naranjo AH, Van Ryn C, Bagatell R, Matthay KK, London WB, Irwin MS, Shimada H, Granger MM, Hogarty MD, Park JR, DuBois SG
• Expression of Five Neuroblastoma Genes in Bone Marrow or Blood of Patients with Relapsed/Refractory Neuroblastoma Provides a New Biomarker for Disease and Prognosis.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Marachelian A, Villablanca JG, Liu CW, Liu B, Goodarzian F, Lai HA, Shimada H, Tran HC, Parra JA, Gallego R, Bedrossian N, Young S, Czarnecki S, Kennedy R, Weiss BD, Goldsmith K, Granger M, Matthay KK…
• Peripheral Blood Biomarkers Associated With Toxicity and Treatment Characteristics After 131I- Metaiodobenzylguanidine Therapy in Patients With Neuroblastoma.
  International journal of radiation oncology, biology, physics 2017 Campbell K, Karski EE, Olow A, Edmondson DA, Kohlgruber AC, Coleman M, Haas-Kogan DA, Matthay KK, DuBois SG
• Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017 Park JR, Bagatell R, Cohn SL, Pearson AD, Villablanca JG, Berthold F, Burchill S, Boubaker A, McHugh K, Nuchtern JG, London WB, Seibel NL, Lindwasser OW, Maris JM, Brock P, Schleiermacher G, …
• MIBG avidity correlates with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group.
  Pediatric blood & cancer 2017 DuBois SG, Mody R, Naranjo A, Van Ryn C, Russ D, Oldridge D, Kreissman S, Baker DL, Parisi M, Shulkin BL, Bai H, Diskin SJ, Batra V, Maris JM, Park JR, Matthay KK, Yanik G
• Phase 1 study of sirolimus in combination with oral cyclophosphamide and topotecan in children and young adults with relapsed and refractory solid tumors.
  Oncotarget 2017 Vo KT, Karski EE, Nasholm NM, Allen S, Hollinger F, Gustafson WC, Long-Boyle JR, Shiboski S, Matthay KK, DuBois SG
• Comparison of Clinical Features and Outcomes in Patients With Bilateral Versus Unilateral Adrenal Neuroblastoma.
  Journal of pediatric hematology/oncology 2017 Dinh T, Truong B, Matthay KK, DuBois SG
• Neuroblastoma.
  Nature reviews. Disease primers 2016 Matthay KK, Maris JM, Schleiermacher G, Nakagawara A, Mackall CL, Diller L, Weiss WA
• Patterns of Relapse in High-Risk Neuroblastoma Patients Treated With and Without Total Body Irradiation.
  International journal of radiation oncology, biology, physics 2016 Li R, Polishchuk A, DuBois S, Hawkins R, Lee SW, Bagatell R, Shusterman S, Hill-Kayser C, Al-Sayegh H, Diller L, Haas-Kogan DA, Matthay KK, London WB, Marcus KJ
• Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with (131)I-metaiodobenzylguanidine.
  European journal of cancer (Oxford, England : 1990) 2016 Huibregtse KE, Vo KT, DuBois SG, Fetzko S, Neuhaus J, Batra V, Maris JM, Weiss B, Marachelian A, Yanik GA, Matthay KK
• Transcript Analysis for Internal Biodosimetry Using Peripheral Blood from Neuroblastoma Patients Treated with (131)I-mIBG, a Targeted Radionuclide.
  Radiation research 2016 Edmondson DA, Karski EE, Kohlgruber A, Koneru H, Matthay KK, Allen S, Hartmann CL, Peterson LE, DuBois SG, Coleman MA
• Prognostic significance of pattern and burden of metastatic disease in patients with stage 4 neuroblastoma: A study from the International Neuroblastoma Risk Group database.
  European journal of cancer (Oxford, England : 1990) 2016 Morgenstern DA, London WB, Stephens D, Volchenboum SL, Simon T, Nakagawara A, Shimada H, Schleiermacher G, Matthay KK, Cohn SL, Pearson AD, Irwin MS
• Reply: Is Extended Sedation Necessary for Young Children Receiving High-Dose (131) I-MIBG Therapy?
  Pediatric blood & cancer 2016 Lee JS, Matthay K, DuBois SG, Roy-Burman A
• Erratum to: Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology Group.
  European journal of nuclear medicine and molecular imaging 2016 Temple W, Mendelsohn L, Kim GE, Nekritz E, Gustafson WC, Lin L, Giacomini K, Naranjo A, Van Ryn C, Parisi MT, Shulkin BL, Yanik GA, Kreissman SG, Hogarty M, Matthay KK, DuBois SG
• Targeted antiangiogenic agents in combination with cytotoxic chemotherapy in preclinical and clinical studies in sarcoma.
  Clinical sarcoma research 2016 Vo KT, Matthay KK, DuBois SG
• A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma.
  Pediatric blood & cancer 2016 Villablanca JG, Volchenboum SL, Cho H, Kang MH, Cohn SL, Anderson CP, Marachelian A, Groshen S, Tsao-Wei D, Matthay KK, Maris JM, Hasenauer CE, Czarnecki S, Lai H, Goodarzian F, Shimada H, Reynolds CP
• Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approaches to Neuroblastoma Therapy) Trial.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 DuBois SG, Marachelian A, Fox E, Kudgus RA, Reid JM, Groshen S, Malvar J, Bagatell R, Wagner L, Maris JM, Hawkins R, Courtier J, Lai H, Goodarzian F, Shimada H, Czarnecki S, Tsao-Wei D, Matthay KK, …
• Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Vo KT, Edwards JV, Epling CL, Sinclair E, Hawkins DS, Grier HE, Janeway KA, Barnette P, McIlvaine E, Krailo MD, Barkauskas DA, Matthay KK, Womer RB, Gorlick RG, Lessnick SL, Mackall CL, DuBois SG
• Physician Perspectives on Palliative Care for Children With Neuroblastoma: An International Context.
  Pediatric blood & cancer 2016 Balkin EM, Thompson D, Colson KE, Lam CG, Matthay KK
• Identification of patient subgroups with markedly disparate rates of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group project.
  Cancer 2015 Thompson D, Vo KT, London WB, Fischer M, Ambros PF, Nakagawara A, Brodeur GM, Matthay KK, DuBois SG
• Extended Sedation With Continuous Midazolam or Dexmedetomidine Infusion for Young Children Receiving 131 I-MIBG Radiopharmaceutical Therapy for Advanced Neuroblastoma.
  Pediatric blood & cancer 2015 Lee JS, Wu R, Wong T, DuBois SG, Matthay K, Gustafson C, Hawkins R, Roy-Burman A
• Evaluation and Outcome of Central Nervous System Involvement in Pediatric Acute Lymphoblastic Leukemia in Dar es Salaam, Tanzania.
  Pediatric blood & cancer 2015 Cohler C, Jumanne S, Kaijage J, DuBois SG, Scanlan P, Matthay KK
• Impact of Whole-Body Radiation Dose on Response and Toxicity in Patients With Neuroblastoma After Therapy With 131 I-Metaiodobenzylguanidine (MIBG).
  Pediatric blood & cancer 2015 Trieu M, DuBois SG, Pon E, Nardo L, Hawkins RA, Marachelian A, Twist CJ, Park JR, Matthay KK
• Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology Group.
  European journal of nuclear medicine and molecular imaging 2015 Temple W, Mendelsohn L, Kim GE, Nekritz E, Gustafson WC, Lin L, Giacomini K, Naranjo A, Van Ryn C, Yanik GA, Kreissman SG, Hogarty M, Matthay KK, DuBois SG
• Advances in Risk Classification and Treatment Strategies for Neuroblastoma.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015 Pinto NR, Applebaum MA, Volchenboum SL, Matthay KK, London WB, Ambros PF, Nakagawara A, Berthold F, Schleiermacher G, Park JR, Valteau-Couanet D, Pearson AD, Cohn SL
• Different outcomes for relapsed versus refractory neuroblastoma after therapy with (131)I-metaiodobenzylguanidine ((131)I-MIBG).
  European journal of cancer (Oxford, England : 1990) 2015 Zhou MJ, Doral MY, DuBois SG, Villablanca JG, Yanik GA, Matthay KK
• Pilot study of intravenous melphalan combined with continuous infusion L-S,R-buthionine sulfoximine for children with recurrent neuroblastoma.
  Pediatric blood & cancer 2015 Anderson CP, Matthay KK, Perentesis JP, Neglia JP, Bailey HH, Villablanca JG, Groshen S, Hasenauer B, Maris JM, Seeger RC, Reynolds CP
• Patient-specific dosimetry using pretherapy [¹²⁴I]m-iodobenzylguanidine ([¹²⁴I]mIBG) dynamic PET/CT imaging before [¹³¹I]mIBG targeted radionuclide therapy for neuroblastoma.
  Molecular imaging and biology 2015 Huang SY, Bolch WE, Lee C, Van Brocklin HF, Pampaloni MH, Hawkins RA, Sznewajs A, DuBois SG, Matthay KK, Seo Y
• SIOP-PODC adapted risk stratification and treatment guidelines: Recommendations for neuroblastoma in low- and middle-income settings.
  Pediatric blood & cancer 2015 Parikh NS, Howard SC, Chantada G, Israels T, Khattab M, Alcasabas P, Lam CG, Faulkner L, Park JR, London WB, Matthay KK, International Society of Pediatric Oncology
• Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2015 DuBois SG, Groshen S, Park JR, Haas-Kogan DA, Yang X, Geier E, Chen E, Giacomini K, Weiss B, Cohn SL, Granger MM, Yanik GA, Hawkins R, Courtier J, Jackson H, Goodarzian F, Shimada H, Czarnecki S, Tsao…
• 131I-metaiodobenzylguanidine with intensive chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma. A new approaches to neuroblastoma therapy (NANT) phase II study.
  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2015 Yanik GA, Villablanca JG, Maris JM, Weiss B, Groshen S, Marachelian A, Park JR, Tsao-Wei D, Hawkins R, Shulkin BL, Jackson H, Goodarzian F, Shimada H, Courtier J, Hutchinson R, Haas-Koga D, Hasenauer …
• Phase I/II study of (131)I-MIBG with vincristine and 5 days of irinotecan for advanced neuroblastoma.
  British journal of cancer 2015 DuBois SG, Allen S, Bent M, Hilton JF, Hollinger F, Hawkins R, Courtier J, Mosse YP, Matthay KK
• Reply to N.-K.V. Cheung et al.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2014 Matthay KK, London WB, Maris J, Adamson PC, Park JR
• Clinical Features and Outcomes Differ between Skeletal and Extraskeletal Osteosarcoma.
  Sarcoma 2014 Thampi S, Matthay KK, Boscardin WJ, Goldsby R, DuBois SG
• Drugging MYCN through an allosteric transition in Aurora kinase A.
  Cancer cell 2014 Gustafson WC, Meyerowitz JG, Nekritz EA, Chen J, Benes C, Charron E, Simonds EF, Seeger R, Matthay KK, Hertz NT, Eilers M, Shokat KM, Weiss WA
• Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2014 Vo KT, Matthay KK, Neuhaus J, London WB, Hero B, Ambros PF, Nakagawara A, Miniati D, Wheeler K, Pearson AD, Cohn SL, DuBois SG
• Pediatric cancer type predicts infection rate, need for critical care intervention, and mortality in the pediatric intensive care unit.
  Intensive care medicine 2014 Zinter MS, DuBois SG, Spicer A, Matthay K, Sapru A
• Significance of clinical and biologic features in Stage 3 neuroblastoma: a report from the International Neuroblastoma Risk Group project.
  Pediatric blood & cancer 2014 Meany HJ, London WB, Ambros PF, Matthay KK, Monclair T, Simon T, Garaventa A, Berthold F, Nakagawara A, Cohn SL, Pearson AD, Park JR
• Symptom assessment in pediatric oncology: how should concordance between children's and parents' reports be evaluated?
  Cancer nursing 2014 Baggott C, Cooper BA, Marina N, Matthay KK, Miaskowski C
• Likelihood of bone recurrence in prior sites of metastasis in patients with high-risk neuroblastoma.
  International journal of radiation oncology, biology, physics 2014 Polishchuk AL, Li R, Hill-Kayser C, Little A, Hawkins RA, Hamilton J, Lau M, Tran HC, Strahlendorf C, Lemons RS, Weinberg V, Matthay KK, DuBois SG, Marcus KJ, Bagatell R, Haas-Kogan DA
• Probable fatal drug interaction between intravenous fenretinide, ceftriaxone, and acetaminophen: a case report from a New Approaches to Neuroblastoma (NANT) Phase I study.
  BMC research notes 2014 Kang MH, Villablanca JG, Glade Bender JL, Matthay KK, Groshen S, Sposto R, Czarnecki S, Ames MM, Reynolds CP, Marachelian A, Maurer BJ
• Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group Database.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2014 Morgenstern DA, London WB, Stephens D, Volchenboum SL, Hero B, Di Cataldo A, Nakagawara A, Shimada H, Ambros PF, Matthay KK, Cohn SL, Pearson AD, Irwin MS
• Neuroblastoma in older children, adolescents and young adults: a report from the International Neuroblastoma Risk Group project.
  Pediatric blood & cancer 2013 Mossé YP, Deyell RJ, Berthold F, Nagakawara A, Ambros PF, Monclair T, Cohn SL, Pearson AD, London WB, Matthay KK
• Current treatment and outcome for childhood acute leukemia in Tanzania.
  Pediatric blood & cancer 2013 Kersten E, Scanlan P, Dubois SG, Matthay KK
• Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial.
  The Lancet. Oncology 2013 Kreissman SG, Seeger RC, Matthay KK, London WB, Sposto R, Grupp SA, Haas-Kogan DA, Laquaglia MP, Yu AL, Diller L, Buxton A, Park JR, Cohn SL, Maris JM, Reynolds CP, Villablanca JG
• Adverse impact of regional lymph node involvement in osteosarcoma.
  European journal of cancer (Oxford, England : 1990) 2013 Thampi S, Matthay KK, Goldsby R, DuBois SG
• Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: a report from the New Approaches to Neuroblastoma Therapy (NANT) consortium.
  Pediatric blood & cancer 2013 Maurer BJ, Kang MH, Villablanca JG, Janeba J, Groshen S, Matthay KK, Sondel PM, Maris JM, Jackson HA, Goodarzian F, Shimada H, Czarnecki S, Hasenauer B, Reynolds CP, Marachelian A
• Superselective intra-arterial melphalan therapy for newly diagnosed and refractory retinoblastoma: results from a single institution.
  Clinical ophthalmology (Auckland, N.Z.) 2013 Thampi S, Hetts SW, Cooke DL, Stewart PJ, Robbins E, Banerjee A, Dubois SG, Char D, Halbach V, Matthay K
• Acute changes in blood pressure in patients with neuroblastoma treated with ¹³¹I-metaiodobenzylguanidine (MIBG).
  Pediatric blood & cancer 2013 Wong T, Matthay KK, Boscardin WJ, Hawkins RA, Brakeman PR, DuBois SG
• 131I-Metaiodobenzylguanidine therapy in children with advanced neuroblastoma.
  The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of... 2013 DuBois SG, Matthay KK
• Poly (ADP-Ribose) polymerase inhibitor MK-4827 together with radiation as a novel therapy for metastatic neuroblastoma.
  Anticancer research 2013 Mueller S, Bhargava S, Molinaro AM, Yang X, Kolkowitz I, Olow A, Wehmeijer N, Orbach S, Chen J, Matthay KK, Haas-Kogan DA
• Infections in hospitalized children and young adults with acute leukemia in Morocco.
  Pediatric blood & cancer 2013 Depasse J, Caniza MA, Quessar A, Khattab M, Hessissen L, Ribeiro R, Cherkaoui S, Benchekroun S, Matthay KK
• Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2013 Yanik GA, Parisi MT, Shulkin BL, Naranjo A, Kreissman SG, London WB, Villablanca JG, Maris JM, Park JR, Cohn SL, McGrady P, Matthay KK
• Relevance of historical therapeutic approaches to the contemporary treatment of pediatric solid tumors.
  Pediatric blood & cancer 2013 Green DM, Kun LE, Matthay KK, Meadows AT, Meyer WH, Meyers PA, Spunt SL, Robison LL, Hudson MM
• Targeted isotretinoin in neuroblastoma: kinetics, genetics, or absorption.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2012 Matthay KK
• Tumor dosimetry using [124I]m-iodobenzylguanidine microPET/CT for [131I]m-iodobenzylguanidine treatment of neuroblastoma in a murine xenograft model.
  Molecular imaging and biology 2012 Seo Y, Gustafson WC, Dannoon SF, Nekritz EA, Lee CL, Murphy ST, VanBrocklin HF, Hernandez-Pampaloni M, Haas-Kogan DA, Weiss WA, Matthay KK
• 131I-MIBG followed by consolidation with busulfan, melphalan and autologous stem cell transplantation for refractory neuroblastoma.
  Pediatric blood & cancer 2012 French S, DuBois SG, Horn B, Granger M, Hawkins R, Pass A, Plummer E, Matthay K
• Evaluation of Norepinephrine Transporter Expression and Metaiodobenzylguanidine Avidity in Neuroblastoma: A Report from the Children's Oncology Group.
  International journal of molecular imaging 2012 Dubois SG, Geier E, Batra V, Yee SW, Neuhaus J, Segal M, Martinez D, Pawel B, Yanik G, Naranjo A, London WB, Kreissman S, Baker D, Attiyeh E, Hogarty MD, Maris JM, Giacomini K, Matthay KK
• Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project.
  British journal of cancer 2012 Schleiermacher G, Mosseri V, London WB, Maris JM, Brodeur GM, Attiyeh E, Haber M, Khan J, Nakagawara A, Speleman F, Noguera R, Tonini GP, Fischer M, Ambros I, Monclair T, Matthay KK, Ambros P, Cohn SL…
• Characteristics and outcomes of patients with Ewing sarcoma over 40 years of age at diagnosis.
  Cancer epidemiology 2012 Karski EE, Matthay KK, Neuhaus JM, Goldsby RE, Dubois SG
• Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 Asgharzadeh S, Salo JA, Ji L, Oberthuer A, Fischer M, Berthold F, Hadjidaniel M, Liu CW, Metelitsa LS, Pique-Regi R, Wakamatsu P, Villablanca JG, Kreissman SG, Matthay KK, Shimada H, London WB, Sposto…
• Evaluation of plasma annexin V levels in children and young adults with solid tumors.
  The International journal of biological markers 2012 Applebaum MA, Sambrano E, Lee S, Goldsby R, Matthay KK, DuBois SG
• Dose escalation study of no-carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trial.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2012 Matthay KK, Weiss B, Villablanca JG, Maris JM, Yanik GA, Dubois SG, Stubbs J, Groshen S, Tsao-Wei D, Hawkins R, Jackson H, Goodarzian F, Daldrup-Link H, Panigrahy A, Towbin A, Shimada H, Barrett J, …
• Promising therapeutic targets in neuroblastoma.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2012 Matthay KK, George RE, Yu AL
• Proteinuria in metastatic pheochromocytoma is associated with an increased risk of Acute Respiratory Distress Syndrome, spontaneously or after therapy with 131I-meta-iodobenzylguanidine (131I-MIBG).
  Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2012 Porzig A, Matthay KK, Dubois S, Pampaloni M, Damon L, Hawkins R, Goldsby R, Hollinger F, Fitzgerald P
• The significance of serial histopathology in a residual mass for outcome of intermediate risk stage 3 neuroblastoma.
  Pediatric blood & cancer 2012 Marachelian A, Shimada H, Sano H, Jackson H, Stein J, Sposto R, Matthay KK, Baker D, Villablanca JG
• Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 Strother DR, London WB, Schmidt ML, Brodeur GM, Shimada H, Thorner P, Collins MH, Tagge E, Adkins S, Reynolds CP, Murray K, Lavey RS, Matthay KK, Castleberry R, Maris JM, Cohn SL
• Phase I study of vincristine, irinotecan, and ¹³¹I-metaiodobenzylguanidine for patients with relapsed or refractory neuroblastoma: a new approaches to neuroblastoma therapy trial.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2012 DuBois SG, Chesler L, Groshen S, Hawkins R, Goodarzian F, Shimada H, Yanik G, Tagen M, Stewart C, Mosse YP, Maris JM, Tsao-Wei D, Marachelian A, Villablanca JG, Matthay KK
• Paracrine signaling through MYCN enhances tumor-vascular interactions in neuroblastoma.
  Science translational medicine 2012 Chanthery YH, Gustafson WC, Itsara M, Persson A, Hackett CS, Grimmer M, Charron E, Yakovenko S, Kim G, Matthay KK, Weiss WA
• Symptom cluster analyses based on symptom occurrence and severity ratings among pediatric oncology patients during myelosuppressive chemotherapy.
  Cancer nursing 2012 Baggott C, Cooper BA, Marina N, Matthay KK, Miaskowski C
• Predictors of acute chemotherapy-associated toxicity in patients with Ewing sarcoma.
  Pediatric blood & cancer 2011 Sharib JM, Cyrus J, Horvai A, Gray Hazard FK, Neuhaus J, Matthay KK, Goldsby R, Marina N, DuBois SG
• Characteristics and outcome of patients with ganglioneuroblastoma, nodular subtype: a report from the INRG project.
  European journal of cancer (Oxford, England : 1990) 2011 Angelini P, London WB, Cohn SL, Pearson AD, Matthay KK, Monclair T, Ambros PF, Shimada H, Leuschner I, Peuchmaur M, Irwin MS, Baruchel S
• Pilot induction regimen incorporating pharmacokinetically guided topotecan for treatment of newly diagnosed high-risk neuroblastoma: a Children's Oncology Group study.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Park JR, Scott JR, Stewart CF, London WB, Naranjo A, Santana VM, Shaw PJ, Cohn SL, Matthay KK
• Prognostic value of the stage 4S metastatic pattern and tumor biology in patients with metastatic neuroblastoma diagnosed between birth and 18 months of age.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Taggart DR, London WB, Schmidt ML, DuBois SG, Monclair TF, Nakagawara A, De Bernardi B, Ambros PF, Pearson AD, Cohn SL, Matthay KK
• Progress towards personalized therapeutics: biologic- and risk-directed therapy for neuroblastoma.
  Expert review of neurotherapeutics 2011 Gustafson WC, Matthay KK
• Evaluation of polymorphisms in EWSR1 and risk of Ewing sarcoma: a report from the Childhood Cancer Survivor Study.
  Pediatric blood & cancer 2011 DuBois SG, Goldsby R, Segal M, Woo J, Copren K, Kane JP, Pullinger CR, Matthay KK, Witte J, Lessnick SL, Robison LL, Bhatia S, Strong LC
• Clinical and biologic features predictive of survival after relapse of neuroblastoma: a report from the International Neuroblastoma Risk Group project.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 London WB, Castel V, Monclair T, Ambros PF, Pearson AD, Cohn SL, Berthold F, Nakagawara A, Ladenstein RL, Iehara T, Matthay KK
• Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project.
  Radiology 2011 Brisse HJ, McCarville MB, Granata C, Krug KB, Wootton-Gorges SL, Kanegawa K, Giammarile F, Schmidt M, Shulkin BL, Matthay KK, Lewington VJ, Sarnacki S, Hero B, Kaneko M, London WB, Pearson AD, Cohn SL…
• Cooperation of the HDAC inhibitor vorinostat and radiation in metastatic neuroblastoma: efficacy and underlying mechanisms.
  Cancer letters 2011 Mueller S, Yang X, Sottero TL, Gragg A, Prasad G, Polley MY, Weiss WA, Matthay KK, Davidoff AM, DuBois SG, Haas-Kogan DA
• Vorinostat increases expression of functional norepinephrine transporter in neuroblastoma in vitro and in vivo model systems.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2011 More SS, Itsara M, Yang X, Geier EG, Tadano MK, Seo Y, Vanbrocklin HF, Weiss WA, Mueller S, Haas-Kogan DA, Dubois SG, Matthay KK, Giacomini KM
• Response, survival, and toxicity after iodine-131-metaiodobenzylguanidine therapy for neuroblastoma in preadolescents, adolescents, and adults.
  Cancer 2011 Polishchuk AL, Dubois SG, Haas-Kogan D, Hawkins R, Matthay KK
• Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study.
  Cancer chemotherapy and pharmacology 2011 Minturn JE, Evans AE, Villablanca JG, Yanik GA, Park JR, Shusterman S, Groshen S, Hellriegel ET, Bensen-Kennedy D, Matthay KK, Brodeur GM, Maris JM
• Comparison of ¹²³I-metaiodobenzylguanidine (MIBG) and ¹³¹I-MIBG semi-quantitative scores in predicting survival in patients with stage 4 neuroblastoma: a report from the Children's Oncology Group.
  Pediatric blood & cancer 2011 Naranjo A, Parisi MT, Shulkin BL, London WB, Matthay KK, Kreissman SG, Yanik GA
• Clinical features and outcomes in patients with extraskeletal Ewing sarcoma.
  Cancer 2011 Applebaum MA, Worch J, Matthay KK, Goldsby R, Neuhaus J, West DC, Dubois SG
• Racial differences in the incidence of mesenchymal tumors associated with EWSR1 translocation.
  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011 Worch J, Cyrus J, Goldsby R, Matthay KK, Neuhaus J, DuBois SG
• Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: a report from the International Neuroblastoma Risk Group Project.
  European journal of cancer (Oxford, England : 1990) 2010 Moroz V, Machin D, Faldum A, Hero B, Iehara T, Mosseri V, Ladenstein R, De Bernardi B, Rubie H, Berthold F, Matthay KK, Monclair T, Ambros PF, Pearson AD, Cohn SL, London WB
• A phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: a new approaches to neuroblastoma therapy (NANT) study.
  Pediatric blood & cancer 2010 Russell HV, Groshen SG, Ara T, DeClerck YA, Hawkins R, Jackson HA, Daldrup-Link HE, Marachelian A, Skerjanec A, Park JR, Katzenstein H, Matthay KK, Blaney SM, Villablanca JG
• Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma.
  The New England journal of medicine 2010 Yu AL, Gilman AL, Ozkaynak MF, London WB, Kreissman SG, Chen HX, Smith M, Anderson B, Villablanca JG, Matthay KK, Shimada H, Grupp SA, Seeger R, Reynolds CP, Buxton A, Reisfeld RA, Gillies SD, Cohn SL…
• Outcome after reduced chemotherapy for intermediate-risk neuroblastoma.
  The New England journal of medicine 2010 Baker DL, Schmidt ML, Cohn SL, Maris JM, London WB, Buxton A, Stram D, Castleberry RP, Shimada H, Sandler A, Shamberger RC, Look AT, Reynolds CP, Seeger RC, Matthay KK, Children’s Oncology Group
• Thyroid and hepatic function after high-dose 131 I-metaiodobenzylguanidine (131 I-MIBG) therapy for neuroblastoma.
  Pediatric blood & cancer 2010 Quach A, Ji L, Mishra V, Sznewajs A, Veatch J, Huberty J, Franc B, Sposto R, Groshen S, Wei D, Fitzgerald P, Maris JM, Yanik G, Hawkins RA, Villablanca JG, Matthay KK
• Radiation dose estimation using preclinical imaging with 124I-metaiodobenzylguanidine (MIBG) PET.
  Medical physics 2010 Lee CL, Wahnishe H, Sayre GA, Cho HM, Kim HJ, Hernandez-Pampaloni M, Hawkins RA, Dannoon SF, VanBrocklin HF, Itsara M, Weiss WA, Yang X, Haas-Kogan DA, Matthay KK, Seo Y
• Changes in children's reports of symptom occurrence and severity during a course of myelosuppressive chemotherapy.
  Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses 2010 Baggott C, Dodd M, Kennedy C, Marina N, Matthay KK, Cooper BA, Miaskowski C
• Osteosarcoma in children 5 years of age or younger at initial diagnosis.
  Pediatric blood & cancer 2010 Worch J, Matthay KK, Neuhaus J, Goldsby R, DuBois SG
• Phase II randomized comparison of topotecan plus cyclophosphamide versus topotecan alone in children with recurrent or refractory neuroblastoma: a Children's Oncology Group study.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 London WB, Frantz CN, Campbell LA, Seeger RC, Brumback BA, Cohn SL, Matthay KK, Castleberry RP, Diller L
• Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force.
  British journal of cancer 2010 Matthay KK, Shulkin B, Ladenstein R, Michon J, Giammarile F, Lewington V, Pearson AD, Cohn SL
• Peripheral blood stem cell support for multiple cycles of dose intensive induction therapy is feasible with little risk of tumor contamination in advanced stage neuroblastoma: a report from the Childrens Oncology Group.
  Pediatric blood & cancer 2010 Bensimhon P, Villablanca JG, Sender LS, Matthay KK, Park JR, Seeger R, London WB, Yap JS, Kreissman SG
• An evaluation of the factors that affect the health-related quality of life of children following myelosuppressive chemotherapy.
  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2010 Baggott CR, Dodd M, Kennedy C, Marina N, Matthay KK, Cooper B, Miaskowski C
• Ethnic and racial differences in patients with Ewing sarcoma.
  Cancer 2010 Worch J, Matthay KK, Neuhaus J, Goldsby R, DuBois SG
• Flow cytometric detection of Ewing sarcoma cells in peripheral blood and bone marrow.
  Pediatric blood & cancer 2010 Dubois SG, Epling CL, Teague J, Matthay KK, Sinclair E
• Increasing incidence of neuroblastoma and potentially higher associated mortality of children from nonmetropolitan areas: analysis of the surveillance, epidemiology, and end results database.
  Journal of pediatric hematology/oncology 2009 Hsieh MH, Meng MV, Walsh TJ, Matthay KK, Baskin LS
• Neuroblastoma: biology and staging.
  Current oncology reports 2009 Mueller S, Matthay KK
• Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastoma.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Taggart DR, Han MM, Quach A, Groshen S, Ye W, Villablanca JG, Jackson HA, Mari Aparici C, Carlson D, Maris J, Hawkins R, Matthay KK
• Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG.
  Pediatric blood & cancer 2009 Okamatsu C, London WB, Naranjo A, Hogarty MD, Gastier-Foster JM, Look AT, LaQuaglia M, Maris JM, Cohn SL, Matthay KK, Seeger RC, Saji T, Shimada H
• Decreased aortic growth and middle aortic syndrome in patients with neuroblastoma after radiation therapy.
  Pediatric radiology 2009 Sutton EJ, Tong RT, Gillis AM, Henning TD, Weinberg VA, Boddington S, Haas-Kogan DA, Matthay K, Sha V, Gooding C, Coakley FV, Daldrup-Link H
• Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paraganglioma.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Gonias S, Goldsby R, Matthay KK, Hawkins R, Price D, Huberty J, Damon L, Linker C, Sznewajs A, Shiboski S, Fitzgerald P
• Successful treatment of high risk and recurrent pediatric desmoids using radiation as a component of multimodality therapy.
  International journal of radiation oncology, biology, physics 2009 Jabbari S, Andolino D, Weinberg V, Missett BT, Law J, Wara WM, O'Donnell RJ, Matthay KK, DuBois SG, Goldsby R, Haas-Kogan DA
• Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force.
  British journal of cancer 2009 Beiske K, Burchill SA, Cheung IY, Hiyama E, Seeger RC, Cohn SL, Pearson AD, Matthay KK, International neuroblastoma Risk Group Task Force
• Iodine-131--metaiodobenzylguanidine double infusion with autologous stem-cell rescue for neuroblastoma: a new approaches to neuroblastoma therapy phase I study.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Matthay KK, Quach A, Huberty J, Franc BL, Hawkins RA, Jackson H, Groshen S, Shusterman S, Yanik G, Veatch J, Brophy P, Villablanca JG, Maris JM
• Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Matthay KK, Reynolds CP, Seeger RC, Shimada H, Adkins ES, Haas-Kogan D, Gerbing RB, London WB, Villablanca JG
• Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium study.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Wagner LM, Villablanca JG, Stewart CF, Crews KR, Groshen S, Reynolds CP, Park JR, Maris JM, Hawkins RA, Daldrup-Link HE, Jackson HA, Matthay KK
• Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group.
  Pediatric blood & cancer 2009 Park JR, Villablanca JG, London WB, Gerbing RB, Haas-Kogan D, Adkins ES, Attiyeh EF, Maris JM, Seeger RC, Reynolds CP, Matthay KK, Children's Oncology Group
• Phase I study of ch14.18 with granulocyte-macrophage colony-stimulating factor and interleukin-2 in children with neuroblastoma after autologous bone marrow transplantation or stem-cell rescue: a report from the Children's Oncology Group.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008 Gilman AL, Ozkaynak MF, Matthay KK, Krailo M, Yu AL, Gan J, Sternberg A, Hank JA, Seeger R, Reaman GH, Sondel PM
• Radiolabeled metaiodobenzylguanidine for imaging and therapy of neuroblastoma.
  The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of... 2008 Taggart D, Dubois S, Matthay KK
• Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma: a report from the International Neuroblastoma Risk Group database.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008 Bagatell R, Beck-Popovic M, London WB, Zhang Y, Pearson AD, Matthay KK, Monclair T, Ambros PF, Cohn SL, International Neuroblastoma Risk Group
• The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008 Cohn SL, Pearson AD, London WB, Monclair T, Ambros PF, Brodeur GM, Faldum A, Hero B, Iehara T, Machin D, Mosseri V, Simon T, Garaventa A, Castel V, Matthay KK, INRG Task Force
• The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008 Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K, Kaneko M, London WB, Matthay KK, Nuchtern JG, von Schweinitz D, Simon T, Cohn SL, Pearson AD, INRG Task Force
• Impact of body composition on pharmacokinetics of doxorubicin in children: a Glaser Pediatric Research Network study.
  Cancer chemotherapy and pharmacology 2008 Thompson PA, Rosner GL, Matthay KK, Moore TB, Bomgaars LR, Ellis KJ, Renbarger J, Berg SL
• Chemotherapy-induced apoptosis in a transgenic model of neuroblastoma proceeds through p53 induction.
  Neoplasia (New York, N.Y.) 2008 Chesler L, Goldenberg DD, Collins R, Grimmer M, Kim GE, Tihan T, Nguyen K, Yakovenko S, Matthay KK, Weiss WA
• Lung metastases in neuroblastoma at initial diagnosis: A report from the International Neuroblastoma Risk Group (INRG) project.
  Pediatric blood & cancer 2008 Dubois SG, London WB, Zhang Y, Matthay KK, Monclair T, Ambros PF, Cohn SL, Pearson A, Diller L
• Diagnostic value of PET/CT for the staging and restaging of pediatric tumors.
  European journal of nuclear medicine and molecular imaging 2008 Kleis M, Daldrup-Link H, Matthay K, Goldsby R, Lu Y, Schuster T, Schreck C, Chu PW, Hawkins RA, Franc BL
• Hepatic absorbed radiation dosimetry during I-131 metaiodobenzylguanidine (MIBG) therapy for refractory neuroblastoma.
  European journal of nuclear medicine and molecular imaging 2008 Koral KF, Huberty JP, Frame B, Matthay KK, Maris JM, Regan D, Normolle D, Yanik GA
• Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastoma.
  Nuclear medicine and biology 2008 DuBois SG, Matthay KK
• Chemotherapy for neuroblastoma: does it hit the target?
  The Lancet. Oncology 2008 Matthay KK
• Nordihydroguaiaretic acid inhibits insulin-like growth factor signaling, growth, and survival in human neuroblastoma cells.
  Journal of cellular biochemistry 2007 Meyer GE, Chesler L, Liu D, Gable K, Maddux BA, Goldenberg DD, Youngren JF, Goldfine ID, Weiss WA, Matthay KK, Rosenthal SM
• Hearing loss, quality of life, and academic problems in long-term neuroblastoma survivors: a report from the Children's Oncology Group.
  Pediatrics 2007 Gurney JG, Tersak JM, Ness KK, Landier W, Matthay KK, Schmidt ML, Children's Oncology Group
• A phase 2 trial of all-trans-retinoic acid in combination with interferon-alpha2a in children with recurrent neuroblastoma or Wilms tumor: A Pediatric Oncology Branch, NCI and Children's Oncology Group Study.
  Pediatric blood & cancer 2007 Adamson PC, Matthay KK, O'Brien M, Reaman GH, Sato JK, Balis FM
• Long-term outcome and toxicities of intraoperative radiotherapy for high-risk neuroblastoma.
  International journal of radiation oncology, biology, physics 2007 Gillis AM, Sutton E, Dewitt KD, Matthay KK, Weinberg V, Fisch BM, Chan A, Gooding C, Daldrup-Link H, Wara WM, Farmer DL, Harrison MR, Haas-Kogan D
• Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007 Matthay KK, Yanik G, Messina J, Quach A, Huberty J, Cheng SC, Veatch J, Goldsby R, Brophy P, Kersun LS, Hawkins RA, Maris JM
• Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma.
  Pediatric blood & cancer 2006 Messina JA, Cheng SC, Franc BL, Charron M, Shulkin B, To B, Maris JM, Yanik G, Hawkins RA, Matthay KK
• Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification.
  Journal of the National Cancer Institute 2006 Asgharzadeh S, Pique-Regi R, Sposto R, Wang H, Yang Y, Shimada H, Matthay K, Buckley J, Ortega A, Seeger RC
• Inhibition of phosphatidylinositol 3-kinase destabilizes Mycn protein and blocks malignant progression in neuroblastoma.
  Cancer research 2006 Chesler L, Schlieve C, Goldenberg DD, Kenney A, Kim G, McMillan A, Matthay KK, Rowitch D, Weiss WA
• Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG).
  Annals of the New York Academy of Sciences 2006 Fitzgerald PA, Goldsby RE, Huberty JP, Price DC, Hawkins RA, Veatch JJ, Dela Cruz F, Jahan TM, Linker CA, Damon L, Matthay KK
• Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number.
  Cancer research 2006 Wang Q, Diskin S, Rappaport E, Attiyeh E, Mosse Y, Shue D, Seiser E, Jagannathan J, Shusterman S, Bansal M, Khazi D, Winter C, Okawa E, Grant G, Cnaan A, Zhao H, Cheung NK, Gerald W, London W, Matthay…
• International neuroblastoma pathology classification adds independent prognostic information beyond the prognostic contribution of age.
  European journal of cancer (Oxford, England : 1990) 2006 Sano H, Bonadio J, Gerbing RB, London WB, Matthay KK, Lukens JN, Shimada H
• A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology Group.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2006 Osenga KL, Hank JA, Albertini MR, Gan J, Sternberg AG, Eickhoff J, Seeger RC, Matthay KK, Reynolds CP, Twist C, Krailo M, Adamson PC, Reisfeld RA, Gillies SD, Sondel PM, Children's Oncology Group
• Is liver metastasis in neuroblastoma an indication for treatment reduction?
  Pediatric blood & cancer 2006 Matthay KK
• Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium Study.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006 Matthay KK, Tan JC, Villablanca JG, Yanik GA, Veatch J, Franc B, Twomey E, Horn B, Reynolds CP, Groshen S, Seeger RC, Maris JM
• Chromosome 1p and 11q deletions and outcome in neuroblastoma.
  The New England journal of medicine 2005 Attiyeh EF, London WB, Mossé YP, Wang Q, Winter C, Khazi D, McGrady PW, Seeger RC, Look AT, Shimada H, Brodeur GM, Cohn SL, Matthay KK, Maris JM, Children's Oncology Group
• Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004.
  Cancer letters 2005 Matthay KK, Blaes F, Hero B, Plantaz D, De Alarcon P, Mitchell WG, Pike M, Pistoia V
• The role of age in neuroblastoma risk stratification: the German, Italian, and children's oncology group perspectives.
  Cancer letters 2005 London WB, Boni L, Simon T, Berthold F, Twist C, Schmidt ML, Castleberry RP, Matthay KK, Cohn SL, De Bernardi B
• Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005 London WB, Castleberry RP, Matthay KK, Look AT, Seeger RC, Shimada H, Thorner P, Brodeur G, Maris JM, Reynolds CP, Cohn SL
• Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005 Schmidt ML, Lal A, Seeger RC, Maris JM, Shimada H, O'Leary M, Gerbing RB, Matthay KK
• Tumor response and toxicity with multiple infusions of high dose 131I-MIBG for refractory neuroblastoma.
  Pediatric blood & cancer 2005 Howard JP, Maris JM, Kersun LS, Huberty JP, Cheng SC, Hawkins RA, Matthay KK
• Enlarged and prominent nucleoli may be indicative of MYCN amplification: a study of neuroblastoma (Schwannian stroma-poor), undifferentiated/poorly differentiated subtype with high mitosis-karyorrhexis index.
  Cancer 2005 Kobayashi C, Monforte-Munoz HL, Gerbing RB, Stram DO, Matthay KK, Lukens JN, Seeger RC, Shimada H
• TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
  Cancer 2004 Shimada H, Nakagawa A, Peters J, Wang H, Wakamatsu PK, Lukens JN, Matthay KK, Siegel SE, Seeger RC
• Hematologic toxicity of high-dose iodine-131-metaiodobenzylguanidine therapy for advanced neuroblastoma.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004 DuBois SG, Messina J, Maris JM, Huberty J, Glidden DV, Veatch J, Charron M, Hawkins R, Matthay KK
• Efficacy of complete resection for high-risk neuroblastoma: a Children's Cancer Group study.
  Journal of pediatric surgery 2004 Adkins ES, Sawin R, Gerbing RB, London WB, Matthay KK, Haase GM
• Visual attention in long-term survivors of leukemia receiving cranial radiation therapy.
  Journal of the International Neuropsychological Society : JINS 2004 Schatz J, Kramer JH, Ablin AR, Matthay KK
• Neuroblastoma: evolving therapies for a disease with many faces.
  Paediatric drugs 2004 Goldsby RE, Matthay KK
• Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular.
  Cancer 2003 Peuchmaur M, d'Amore ES, Joshi VV, Hata J, Roald B, Dehner LP, Gerbing RB, Stram DO, Lukens JN, Matthay KK, Shimada H
• Immune reconstitution, infectious complications and post transplant supportive care measures after autologous blood and marrow transplantation in children.
  Bone marrow transplantation 2003 Machatschek J, Duda J, Matthay K, Cowan M, Horn B
• Online exclusive: behavioral adjustment of children and adolescents with cancer: teacher, parent, and self-report.
  Oncology nursing forum 2003 Moore IM, Challinor J, Pasvogel A, Matthay K, Hutter J, Kaemingk K
• Retinoid therapy of high-risk neuroblastoma.
  Cancer letters 2003 Reynolds CP, Matthay KK, Villablanca JG, Maurer BJ
• High-dose 131I-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma.
  Cancer 2003 Rose B, Matthay KK, Price D, Huberty J, Klencke B, Norton JA, Fitzgerald PA
• Central nervous system metastases in neuroblastoma: radiologic, clinical, and biologic features in 23 patients.
  Cancer 2003 Matthay KK, Brisse H, Couanet D, Couturier J, Bénard J, Mosseri V, Edeline V, Lumbroso J, Valteau-Couanet D, Michon J
• Correlation of early metastatic response by 123I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastoma.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003 Matthay KK, Edeline V, Lumbroso J, Tanguy ML, Asselain B, Zucker JM, Valteau-Couanet D, Hartmann O, Michon J
• Secondary myelodysplastic syndrome and leukemia following 131I-metaiodobenzylguanidine therapy for relapsed neuroblastoma.
  Journal of pediatric hematology/oncology 2003 Weiss B, Vora A, Huberty J, Hawkins RA, Matthay KK
• Prenatal origin of childhood acute myeloid leukemias harboring chromosomal rearrangements t(15;17) and inv(16).
  Blood 2003 McHale CM, Wiemels JL, Zhang L, Ma X, Buffler PA, Feusner J, Matthay K, Dahl G, Smith MT
• Impact of radiotherapy for high-risk neuroblastoma: a Children's Cancer Group study.
  International journal of radiation oncology, biology, physics 2003 Haas-Kogan DA, Swift PS, Selch M, Haase GM, Seeger RC, Gerbing RB, Stram DO, Matthay KK
• Development and testing of the School Competency Assessment Scale.
  Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses 2003 Challinor J, Moore IK, Kramer R, Pasvogel A, Leung K, Amylon M, Hutter J, Matthay K
• Daycare attendance and risk of childhood acute lymphoblastic leukaemia.
  British journal of cancer 2002 Ma X, Buffler PA, Selvin S, Matthay KK, Wiencke JK, Wiemels JL, Reynolds P
• Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastoma.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002 Yanik GA, Levine JE, Matthay KK, Sisson JC, Shulkin BL, Shapiro B, Hubers D, Spalding S, Braun T, Ferrara JL, Hutchinson RJ
• Pediatric acute blastic natural killer cell leukemia.
  Leukemia & lymphoma 2002 DuBois SG, Etzell JE, Matthay KK, Robbins E, Banerjee A
• Veno-occlusive disease of the liver in children with solid tumors undergoing autologous hematopoietic progenitor cell transplantation: a high incidence in patients with neuroblastoma.
  Bone marrow transplantation 2002 Horn B, Reiss U, Matthay K, McMillan A, Cowan M
• Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
  Cancer 2001 Goto S, Umehara S, Gerbing RB, Stram DO, Brodeur GM, Seeger RC, Lukens JN, Matthay KK, Shimada H
• Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with (131)I-MIBG.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001 Matthay KK, Panina C, Huberty J, Price D, Glidden DV, Tang HR, Hawkins RA, Veatch J, Hasegawa B
• International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
  Cancer 2001 Shimada H, Umehara S, Monobe Y, Hachitanda Y, Nakagawa A, Goto S, Gerbing RB, Stram DO, Lukens JN, Matthay KK
• Long-term neurobehavioral outcomes in children with neuroblastoma and opsoclonus-myoclonus-ataxia syndrome: relationship to MRI findings and anti-neuronal antibodies.
  The Journal of pediatrics 2001 Hayward K, Jeremy RJ, Jenkins S, Barkovich AJ, Gultekin SH, Kramer J, Crittenden M, Matthay KK
• Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study.
  Medical and pediatric oncology 2001 Rudnick E, Khakoo Y, Antunes NL, Seeger RC, Brodeur GM, Shimada H, Gerbing RB, Stram DO, Matthay KK
• Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group.
  Medical and pediatric oncology 2001 Cooper R, Khakoo Y, Matthay KK, Lukens JN, Seeger RC, Stram DO, Gerbing RB, Nakagawa A, Shimada H
• Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplification.
  International journal of cancer 2001 Plantaz D, Vandesompele J, Van Roy N, Lastowska M, Bown N, Combaret V, Favrot MC, Delattre O, Michon J, Bénard J, Hartmann O, Nicholson JC, Ross FM, Brinkschmidt C, Laureys G, Caron H, Matthay KK, …
• Functional and clinical outcomes of limb-sparing therapy for pediatric extremity sarcomas.
  International journal of radiation oncology, biology, physics 2001 Bertucio CS, Wara WM, Matthay KK, Ablin AR, Johnston JO, O'Donnell RJ, Weinberg V, Haas-Kogan DA
• Pulmonary metastases at diagnosis of neuroblastoma in pediatric patients: CT findings and prognosis.
  AJR. American journal of roentgenology 2001 Kammen BF, Matthay KK, Pacharn P, Gerbing R, Brasch RC, Gooding CA
• Neuroblastoma imaging using a combined CT scanner-scintillation camera and 131I-MIBG.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001 Tang HR, Da Silva AJ, Matthay KK, Price DC, Huberty JP, Hawkins RA, Hasegawa BH
• Allelic deletion at chromosome bands 11q14-23 is common in neuroblastoma.
  Medical and pediatric oncology 2001 Maris JM, Guo C, White PS, Hogarty MD, Thompson PM, Stram DO, Gerbing R, Matthay KK, Seeger RC, Brodeur GM
• Chemotherapeutic CNS prophylaxis and neuropsychologic change in children with acute lymphoblastic leukemia: a prospective study.
  Journal of pediatric psychology 2001 Espy KA, Moore IM, Kaufmann PM, Kramer JH, Matthay K, Hutter JJ
• Comprehensive analysis of chromosome 1p deletions in neuroblastoma.
  Medical and pediatric oncology 2001 Maris JM, Guo C, Blake D, White PS, Hogarty MD, Thompson PM, Rajalingam V, Gerbing R, Stram DO, Matthay KK, Seeger RC, Brodeur GM
• Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination.
  Archives of ophthalmology (Chicago, Ill. : 1960) 2001 Uusitalo MS, Van Quill KR, Scott IU, Matthay KK, Murray TG, O'Brien JM
• Loss of heterozygosity for chromosome 14q in neuroblastoma.
  Medical and pediatric oncology 2001 Thompson PM, Seifried BA, Kyemba SK, Jensen SJ, Guo C, Maris JM, Brodeur GM, Stram DO, Seeger RC, Gerbing R, Matthay KK, Matise TC, White PS
• Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: a Children's Cancer Group Study.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000 Ozkaynak MF, Sondel PM, Krailo MD, Gan J, Javorsky B, Reisfeld RA, Matthay KK, Reaman GH, Seeger RC
• Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: a Children's Cancer Group Study.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000 Seeger RC, Reynolds CP, Gallego R, Stram DO, Gerbing RB, Matthay KK
• Multidrug resistance-associated protein 1 (MRP1) expression in neuroblastoma cell lines and primary tumors.
  Medical and pediatric oncology 2000 Goto H, Keshelava N, Matthay KK, Lukens JN, Gerbing RB, Stram DO, Seeger RC, Reynolds CP
• Phase I topotecan preparative regimen for high-risk neuroblastoma, high-grade glioma, and refractory/recurrent pediatric solid tumors.
  Medical and pediatric oncology 2000 Park JR, Slattery J, Gooley T, Hawkins D, Lindsley K, Villablanca JG, Matthay KK, Sanders JE
• Telomerase activity by TRAP assay and telomerase RNA (hTR) expression are predictive of outcome in neuroblastoma.
  Medical and pediatric oncology 2000 Choi LM, Kim NW, Zuo JJ, Gerbing R, Stram D, Lukens JN, Matthay KK, Seeger RC, Reynolds CP
• Cognitive consequences and central nervous system injury following treatment for childhood leukemia.
  Seminars in oncology nursing 2000 Moore IM, Espy KA, Kaufmann P, Kramer J, Kaemingk K, Miketova P, Mollova N, Kaspar M, Pasvogel A, Schram K, Wara W, Hutter J, Matthay K
• Is there a role for retinoids to treat minimal residual disease in neuroblastoma?
  British journal of cancer 2000 Matthay KK, Reynolds CP
• MYCN expression in neuroblastoma: A mixed message?
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000 Matthay KK
• Histopathology defines prognostic subsets of ganglioneuroblastoma, nodular.
  Cancer 2000 Umehara S, Nakagawa A, Matthay KK, Lukens JN, Seeger RC, Stram DO, Gerbing RB, Shimada H
• Is adjuvant therapy ever warranted in localized neuroblastoma.
  Journal of pediatric hematology/oncology 2000 Matthay KK, Stram D
• Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus.
  Journal of pediatric hematology/oncology 2000 Antunes NL, Khakoo Y, Matthay KK, Seeger RC, Stram DO, Gerstner E, Abrey LE, Dalmau J
• Intraoperative radiation therapy for high-risk pediatric neuroblastoma.
  International journal of radiation oncology, biology, physics 2000 Haas-Kogan DA, Fisch BM, Wara WM, Swift PS, Farmer DL, Harrison MR, Albanese C, Weinberg V, Matthay KK
• A phase I dose escalation of combination chemotherapy with granulocyte-macrophage-colony stimulating factor in patients with neuroblastoma.
  Cancer 2000 Fernandez MC, Krailo MD, Gerbing RR, Matthay KK
• Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000 Maris JM, Weiss MJ, Guo C, Gerbing RB, Stram DO, White PS, Hogarty MD, Sulman EP, Thompson PM, Lukens JN, Matthay KK, Seeger RC, Brodeur GM
• Processing speed, working memory, and IQ: a developmental model of cognitive deficits following cranial radiation therapy.
  Neuropsychology 2000 Schatz J, Kramer JH, Ablin A, Matthay KK
• Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000 Schmidt ML, Lukens JN, Seeger RC, Brodeur GM, Shimada H, Gerbing RB, Stram DO, Perez C, Haase GM, Matthay KK
• Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000 Nickerson HJ, Matthay KK, Seeger RC, Brodeur GM, Shimada H, Perez C, Atkinson JB, Selch M, Gerbing RB, Stram DO, Lukens J
• Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000 Perez CA, Matthay KK, Atkinson JB, Seeger RC, Shimada H, Haase GM, Stram DO, Gerbing RB, Lukens JN
• Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.
  The New England journal of medicine 1999 Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK, Swift P, Shimada H, Black CT, Brodeur GM, Gerbing RB, Reynolds CP
• Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas.
  Oncogene 1999 Guo C, White PS, Weiss MJ, Hogarty MD, Thompson PM, Stram DO, Gerbing R, Matthay KK, Seeger RC, Brodeur GM, Maris JM
• The International Neuroblastoma Pathology Classification (the Shimada system).
  Cancer 1999 Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B, Stram DO, Gerbing RB, Lukens JN, Matthay KK, Castleberry RP
• Molecular biology of neuroblastoma.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999 Maris JM, Matthay KK
• Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival.
  Journal of pediatric hematology/oncology 1999 DuBois SG, Kalika Y, Lukens JN, Brodeur GM, Seeger RC, Atkinson JB, Haase GM, Black CT, Perez C, Shimada H, Gerbing R, Stram DO, Matthay KK
• Congenital leukemia: successful treatment of a newborn with t(5;11)(q31;q23).
  Journal of pediatric hematology/oncology 1999 Fernandez MC, Weiss B, Atwater S, Shannon K, Matthay KK
• Intensification of therapy using hematopoietic stem-cell support for high-risk neuroblastoma.
  Pediatric transplantation 1999 Matthay KK
• Somatization, anxiety and depression as measures of health-related quality of life of children/adolescents with cancer.
  International journal of cancer. Supplement = Journal international du cancer. Supplement 1999 Challinor JM, Miaskowski CA, Franck LS, Slaughter RE, Matthay KK, Kramer RF, Veatch JJ, Paul SM, Amylon MD, Moore IM
• Engraftment after myeloablative doses of 131I-metaiodobenzylguanidine followed by autologous bone marrow transplantation for treatment of refractory neuroblastoma.
  Medical and pediatric oncology 1998 Goldberg SS, DeSantes K, Huberty JP, Price D, Hasegawa BH, Reynolds CP, Seeger RC, Hattner R, Matthay KK
• Stage 4S neuroblastoma: what makes it special?
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998 Matthay KK
• Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998 Matthay KK, Perez C, Seeger RC, Brodeur GM, Shimada H, Atkinson JB, Black CT, Gerbing R, Haase GM, Stram DO, Swift P, Lukens JN
• Double-alkylator non-total-body irradiation regimen with autologous hematopoietic stem-cell transplantation in pediatric solid tumors.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998 Ozkaynak MF, Matthay K, Cairo M, Harris RE, Feig S, Reynolds CP, Buckley J, Villablanca JG, Seeger RC
• Hypercalcemia in malignant paraganglioma due to parathyroid hormone-related protein.
  Hormone research 1998 Loh K, Matthay KK, Hoover M, Bracho FA, Cortez AB, Conte FA, Albanese CT, Miller TR, Price DC, Flores AJ, Kaviani A, Shoback D
• Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998 Matthay KK, DeSantes K, Hasegawa B, Huberty J, Hattner RS, Ablin A, Reynolds CP, Seeger RC, Weinberg VK, Price D
• Neuroblastoma: biology and therapy.
  Oncology (Williston Park, N.Y.) 1997 Matthay KK
• The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients.
  Journal of endocrinological investigation 1997 Loh KC, Fitzgerald PA, Matthay KK, Yeo PP, Price DC
• Telomerase expression in primary neuroblastomas.
  European journal of cancer (Oxford, England : 1990) 1997 Reynolds CP, Zuo JJ, Kim NW, Wang H, Lukens JN, Matthay KK, Seeger RC
• The International Neuroblastoma Risk Groups (INRG): a preliminary report.
  European journal of cancer (Oxford, England : 1990) 1997 Castleberry RP, Pritchard J, Ambros P, Berthold F, Brodeur GM, Castel V, Cohn SL, De Bernardi B, Dicks-Mireaux C, Frappaz D, Haase GM, Haber M, Jones DR, Joshi VV, Kaneko M, Kemshead JT, Kogner P, Lee…
• A phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma: a report of the Children's Cancer Group.
  Cancer 1997 Frost JD, Hank JA, Reaman GH, Frierdich S, Seeger RC, Gan J, Anderson PM, Ettinger LJ, Cairo MS, Blazar BR, Krailo MD, Matthay KK, Reisfeld RA, Sondel PM
• Neuroblastoma in adults and adolescents: an indolent course with poor survival.
  Cancer 1997 Franks LM, Bollen A, Seeger RC, Stram DO, Matthay KK
• Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization.
  The American journal of pathology 1997 Plantaz D, Mohapatra G, Matthay KK, Pellarin M, Seeger RC, Feuerstein BG
• Impact of myeloablative therapy with bone marrow transplantation in advanced neuroblastoma.
  Bone marrow transplantation 1996 Matthay KK
• Renal cell carcinoma after therapy for neuroblastoma.
  AJR. American journal of roentgenology 1996 Donnelly LF, Rencken IO, Shardell K, Matthay KK, Miller CR, Vartanian RK, Gooding CA
• Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996 Stram DO, Matthay KK, O'Leary M, Reynolds CP, Haase GM, Atkinson JB, Brodeur GM, Seeger RC
• Disease course and late sequelae of Langerhans' cell histiocytosis: 25-year experience at the University of California, San Francisco.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996 Willis B, Ablin A, Weinberg V, Zoger S, Wara WM, Matthay KK
• Monitoring neovascularity as an indicator to response to chemotherapy in osteogenic and Ewing sarcoma using magnetic resonance angiography.
  Medical and pediatric oncology 1996 Lang P, Vahlensieck M, Matthay KK, Johnston JO, Rosenau W, Gooding CA, Genant HK
• Toxicities of total-body irradiation for pediatric bone marrow transplantation.
  International journal of radiation oncology, biology, physics 1996 Chou RH, Wong GB, Kramer JH, Wara DW, Matthay KK, Crittenden MR, Swift PS, Cowan MJ, Wara WM
• Pelvic neuroblastoma--implications for a new favorable subgroup: a Children's Cancer Group experience.
  Annals of surgical oncology 1995 Haase GM, O'Leary MC, Stram DO, Lukens JN, Seeger RC, Shimada H, Matthay KK
• Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis.
  Journal of the National Cancer Institute 1995 Shimada H, Stram DO, Chatten J, Joshi VV, Hachitanda Y, Brodeur GM, Lukens JN, Matthay KK, Seeger RC
• Primary bone tumors: value of MR angiography for preoperative planning and monitoring response to chemotherapy.
  AJR. American journal of roentgenology 1995 Lang P, Grampp S, Vahlensieck M, Johnston JO, Honda G, Rosenau W, Matthay KK, Peterfy C, Higgins CB, Genant HK
• p53 mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomas.
  Cancer 1995 Ikenberg H, Matthay K, Schmitt B, Bauknecht T, Kiechle-Schwarz M, Göppinger A, Pfleiderer A
• Neuroblastoma: a clinical challenge and biologic puzzle.
  CA: a cancer journal for clinicians 1995 Matthay KK
• Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995 Villablanca JG, Khan AA, Avramis VI, Seeger RC, Matthay KK, Ramsay NK, Reynolds CP
• Hematology and oncology.
  Current opinion in pediatrics 1995 Mentzer WC, Matthay K
• Radiological case of the month. Miliary pulmonary neuroblastoma.
  Archives of pediatrics & adolescent medicine 1995 Kalra R, Zoger S, Kosovich MS, Matthay KK
• Surgical management and outcome of locoregional neuroblastoma: comparison of the Childrens Cancer Group and the international staging systems.
  Journal of pediatric surgery 1995 Haase GM, Atkinson JB, Stram DO, Lukens JN, Matthay KK
• Role of myeloablative therapy in improved outcome for high risk neuroblastoma: review of recent Children's Cancer Group results.
  European journal of cancer (Oxford, England : 1990) 1995 Matthay KK, O'Leary MC, Ramsay NK, Villablanca J, Reynolds CP, Atkinson JB, Haase GM, Stram DO, Seeger RC
• Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: a report from the Childrens Cancer Group.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994 Matthay KK, Seeger RC, Reynolds CP, Stram DO, O'Leary MC, Harris RE, Selch M, Atkinson JB, Haase GM, Ramsay NK
• Normal cerebellar MIBG localization. Implications in the interpretation of delayed scans.
  Clinical nuclear medicine 1994 Hattner RS, Pounds TR, Matthay KK
• Hematology and oncology.
  Current opinion in pediatrics 1994 Mentzer WC, Matthay K
• Comparison of autologous and allogeneic bone marrow transplantation for neuroblastoma.
  Progress in clinical and biological research 1994 Matthay KK, Seeger RC, Reynolds CP, Stram DO, O'Leary M, Harris RE, Selch M, Atkinson JB, Haase G, Hammond GD
• Myeloablative chemoradiotherapy versus continued chemotherapy for high risk neuroblastoma.
  Progress in clinical and biological research 1994 Stram DO, Matthay KK, O'Leary M, Reynolds CP, Seeger RC
• Optimized diagnostic strategy for neuroblastoma in opsoclonus-myoclonus.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1993 Parisi MT, Hattner RS, Matthay KK, Berg BO, Sandler ED
• Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: a Childrens Cancer Group pilot study.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993 Matthay KK, Atkinson JB, Stram DO, Selch M, Reynolds CP, Seeger RC
• Escalating dose of continuous infusion combination chemotherapy for refractory neuroblastoma.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993 Campbell LA, Seeger RC, Harris RE, Villablanca JG, Matthay KK
• Neuroblastoma: dose-related sensitivity of MIBG scanning in detection.
  Radiology 1992 Parisi MT, Matthay KK, Huberty JP, Hattner RS
• Germ-line and somatic p53 gene mutations in multifocal osteogenic sarcoma.
  Proceedings of the National Academy of Sciences of the United States of America 1992 Iavarone A, Matthay KK, Steinkirchner TM, Israel MA
• Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes.
  Biochimica et biophysica acta 1992 Woodle MC, Matthay KK, Newman MS, Hidayat JE, Collins LR, Redemann C, Martin FJ, Papahadjopoulos D
• Prophylactic cranial irradiation dose effects on late cognitive function in children treated for acute lymphoblastic leukemia.
  International journal of radiation oncology, biology, physics 1992 Halberg FE, Kramer JH, Moore IM, Wara WM, Matthay KK, Ablin AR
• Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.
  Proceedings of the National Academy of Sciences of the United States of America 1991 Papahadjopoulos D, Allen TM, Gabizon A, Mayhew E, Matthay K, Huang SK, Lee KD, Woodle MC, Lasic DD, Redemann C
• Role of radiotherapy in neuroblastoma.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991 D'Angio GJ, Matthay KK, Evans AE
• An overview on the treatment of neuroblastoma.
  Journal of nuclear biology and medicine (Turin, Italy : 1991) 1991 Matthay KK
• Efficacy and safety of [131I]metaiodobenzylguanidine therapy for patients with refractory neuroblastoma.
  Journal of nuclear biology and medicine (Turin, Italy : 1991) 1991 Matthay KK, Huberty JP, Hattner RS, Ablin AR, Engelstad BL, Zoger S, Hasegawa BH, Price D
• Solid tumors in children.
  The New England journal of medicine 1991 D'Angio GJ, Matthay KK
• Intensive chemoradiotherapy and autologous bone marrow transplantation for poor prognosis neuroblastoma.
  Progress in clinical and biological research 1991 Seeger RC, Villablanca JG, Matthay KK, Harris R, Moss TJ, Feig SA, Selch M, Ramsay N, Reynolds CP
• Response of neuroblastoma to retinoic acid in vitro and in vivo.
  Progress in clinical and biological research 1991 Reynolds CP, Kane DJ, Einhorn PA, Matthay KK, Crouse VL, Wilbur JR, Shurin SB, Seeger RC
• Total body irradiation and bone marrow transplantation for immunodeficiency disorders in young children.
  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1990 Halberg FE, Wara WM, Weaver KE, Wara DW, Ablin AR, Matthay KK, Mentzer WC, O'Leary MC, Cowan MJ
• Hematologic disorders affecting the lungs.
  Clinics in chest medicine 1989 Edwards JR, Matthay KK
• Comparison of anti-Tac and anti-transferrin receptor-conjugated liposomes for specific drug delivery to adult T-cell leukemia.
  Blood 1989 Hege KM, Daleke DL, Waldmann TA, Matthay KK
• Role of ligand in antibody-directed endocytosis of liposomes by human T-leukemia cells.
  Cancer research 1989 Matthay KK, Abai AM, Cobb S, Hong K, Papahadjopoulos D, Straubinger RM
• Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989 Matthay KK, Sather HN, Seeger RC, Haase GM, Hammond GD
• Ewing's sarcoma of the mandible.
  Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 1989 Langman AW, Kaplan MJ, Matthay K
• Complete pathologic maturation and regression of stage IVS neuroblastoma without treatment.
  Cancer 1988 Haas D, Ablin AR, Miller C, Zoger S, Matthay KK
• Childhood acute lymphoblastic leukemia.
  Pediatric annals 1988 Diamond CA, Matthay KK
• Patient, parent, and physician perspectives on pediatric oncology rounds.
  The Journal of pediatrics 1988 Lewis C, Knopf D, Chastain-Lorber K, Ablin A, Zoger S, Matthay K, Glasser M, Pantell R
• Antibody-directed targeting of liposomes to human cell lines: role of binding and internalization on growth inhibition.
  Cancer research 1987 Berinstein N, Matthay KK, Papahadjopoulos D, Levy R, Sikic BI
• Haploidentical bone marrow transplantation using soybean agglutinin-processed, T-depleted marrow.
  Transplantation proceedings 1987 Matthay K, Wara DW, Ablin AJ, Cowan MJ
• Lymphocyte reconstitution in children receiving soybean agglutinin T-depleted bone marrow transplants.
  Transplantation proceedings 1987 Cowan MJ, McHugh T, Smith W, Wara D, Matthay K, Ablin A, Casavant C, Stites D
• Antibody-directed liposomes: comparison of various ligands for association, endocytosis, and drug delivery.
  Cancer research 1986 Matthay KK, Heath TD, Badger CC, Bernstein ID, Papahadjopoulos D
• Bone marrow in children with acute lymphocytic leukemia: MR relaxation times.
  Radiology 1986 Moore SG, Gooding CA, Brasch RC, Ehman RL, Ringertz HG, Ablin AR, Matthay KK, Zoger S
• Monoclonal antibodies in the diagnosis and treatment of childhood diseases.
  Advances in pediatrics 1985 Matthay KK
• New methodology for liposome targeting to specific cells.
  Annals of the New York Academy of Sciences 1985 Papahadjopoulos D, Heath T, Bragman K, Matthay K
• Spinal cord compression in a child with acute lymphoblastic leukemia.
  The American journal of pediatric hematology/oncology 1985 Lo WD, Matthay KK, Kushner J
• Long-term follow-up and booster immunization with polyvalent pneumococcal polysaccharide in patients with sickle cell anemia.
  The Journal of pediatrics 1984 Weintrub PS, Schiffman G, Addiego JE, Matthay KK, Vichinsky E, Johnson R, Lubin B, Mentzer WC, Ammann AJ
• Specific enhancement of drug delivery to AKR lymphoma by antibody-targeted small unilamellar vesicles.
  Cancer research 1984 Matthay KK, Heath TD, Papahadjopoulos D
• Antibody-directed liposomes: the development of a cell-specific cytotoxic agent.
  Biochemical Society transactions 1984 Heath TD, Bragman KS, Matthay KK, Lopez-Straubinger NG, Papahadjopoulos D
• Prenatal diagnosis of chronic granulomatous disease.
  American journal of medical genetics 1984 Matthay KK, Golbus MS, Wara DW, Mentzer WC
• Increased serum opsonic activity and antibody concentration in patients with sickle cell disease after pneumococcal polysaccharide immunization.
  The Journal of pediatrics 1983 Chudwin DS, Wara DW, Matthay KK, Caulfield MH, Schiffmann G, Mentzer WC, Ammann AJ
• Erythrocyte enzymopathies in the newborn.
  Clinics in haematology 1981 Matthay KK, Mentzer WC
• Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assay.
  Infection and immunity 1981 Matthay KK, Mentzer WC, Wara DW, Preisler HK, Lameris NB, Ammann AJ
• Modification of hemoglobin H disease by sickle trait.
  The Journal of clinical investigation 1979 Matthay KK, Mentzer WC, Dozy AM, Kan YW, Bainton DF
• Intracranial hemorrhage in congenital factor VII deficiency.
  The Journal of pediatrics 1979 Matthay KK, Koerper MA, Ablin AR